Some clinical studies demonstrate that PTHrP expression in the primary tumor correlates with improved patient survival and formation of fewer bone metastases [23, 24], while others report that PTHrP is associated with worse patient outcomes [11, 25, 26]. The gene discussed is PTHLH; the disease is neoplasm.